New Hallbergmoos biotech company: Using nanoparticles to fight cancer. Plectonic Logibody's developments include a nanoswitch that connects immune cells with tumor cells.
In this way, the body's immune system is supposed to target cancer cells. The new treatment approach is considered groundbreaking in medical research. The company plans to move into the premises from mid-2024. About half of the 1,300 square meters will be office space. Not only are modern offices available on site, but also state-of-the-art laboratories, meeting rooms and a spacious social area.